PRESS RELEASE published on 04/28/2023 at 08:00, 1 year 6 months ago Publication of 2022 Annual Report and Accounts & Sustainability Report
PRESS RELEASE published on 04/28/2023 at 08:00, 1 year 6 months ago Report on Payments to Governments for 2022
PRESS RELEASE published on 03/28/2023 at 15:37, 1 year 7 months ago Long Term Incentive Plan (“LTIP”) Award
PRESS RELEASE published on 03/15/2023 at 08:00, 1 year 8 months ago Notice of 2022 Full Year Results and Investor Presentations
Published on 11/21/2024 at 16:30, 1 hour 4 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 33 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 34 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 34 minutes ago Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 34 minutes ago Isaac Ullatil Joins Wellstack Board of Directors
Published on 11/21/2024 at 15:41, 1 hour 52 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 2 hours 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 2 hours 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 2 hours 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 06:58, 10 hours 36 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 14 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 23 hours 49 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 23 hours 49 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 9 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo